CA Patent

CA3041626C — Ophthalmic composition for lowering intraocular pressure

Assigned to Taejoon Pharmaceutical Co Ltd · Expires 2024-04-16 · 2y expired

What this patent protects

The present invention relates to an eye-drop composition for lowering intraocular pressure, the composition comprising latanoprost, polyoxyl 40 hydrogenated castor oil, and sorbitol.

USPTO Abstract

The present invention relates to an eye-drop composition for lowering intraocular pressure, the composition comprising latanoprost, polyoxyl 40 hydrogenated castor oil, and sorbitol.

Drugs covered by this patent

Patent Metadata

Patent number: CA3041626C
Jurisdiction: CA
Classification: —
Expires: 2024-04-16
Drug substance claim: No
Drug product claim: No
Assignee: Taejoon Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.